bibliographicCitation |
Stern HM, Padilla M, Wagner K, Amler L, Ashkenazi A. Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab. Clin Cancer Res. 2010 Mar 01;16(5):1587–96. doi: 10.1158/1078-0432.ccr-09-3108. PMID: 20179215. |